Has Huiyuan Jiang received payments from drug or device companies?

Yes. Drug and device makers reported $4,381 in general payments to Huiyuan Jiang across 139 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Huiyuan Jiang did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Huiyuan Jiang come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Huiyuan Jiang

Neurology with Special Qualifications in Child Neurology · Bakersfield, CANPI 1891718243

Payments from drug & device makers

$4,381in general payments, 2019–2025

Across 139 payments — averaging $31.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Livanova USA, Inc.$2K
UCB, Inc.$592
Neurelis, Inc.$466
Aquestive Therapeutics, Inc.$277
Acadia Pharmaceuticals Inc$182
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$157
plus $911 from 24 others

What the payments were for

Travel & lodging$91821%
Food & beverage$3,45079%
Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Livanova USA, Inc.	43	$1,796
UCB, Inc.	16	$592
Neurelis, Inc.	8	$466
Aquestive Therapeutics, Inc.	14	$277
Acadia Pharmaceuticals Inc	7	$182
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)	3	$157
Sunovion Pharmaceuticals Inc.	12	$128
Biomarin Pharmaceutical Inc.	1	$93
Eisai Inc.	4	$86
Jazz Pharmaceuticals Inc.	3	$63
Novo Nordisk	2	$49
Sarepta Therapeutics, Inc.	2	$45
Supernus Pharmaceuticals, Inc.	2	$44
Greenwich Biosciences, Inc.	2	$43
PTC Therapeutics, Inc.	1	$40
Ascendis Pharma Endocrinology Inc	2	$31
Tolmar Pharmaceuticals, Inc.	1	$29
AstraZeneca	2	$28
Kyowa Kirin, Inc.	1	$26
Catalyst Pharmaceuticals, Inc.	1	$25
Electromed, Inc.	3	$25
Neurocrine Biosciences, Inc.	1	$22
Tolmar, Inc.	1	$21
Takeda Pharmaceuticals U.S.A., Inc.	1	$20
Ipsen Biopharmaceuticals, Inc	1	$19
Xeris Pharmaceuticals, Inc.	1	$18
Sumitomo Pharma America, Inc.	1	$17
Cranial Technologies, Inc	1	$14
Merz North America, Inc.	1	$14
Zogenix Inc.	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,381 in reported general payments places this provider in the 60th percentile of 216 neurology with special qualifications in child neurology providers in California.

See all neurology with special qualifications in child neurology providers in California →

Other neurology with special qualifications in child neurology in Bakersfield

Sabine MuellerSan Francisco$17.5M
Joseph SullivanSan Francisco$1.7M
Rajsekar RajaramanLos Angeles$1.5M
Jonathan SantoroPalo Alto$1.5M
Michelle MonjePalo Alto$1.3M
Jay DesaiLos Angeles$1.2M
Richard HaasSan Diego$1.2M
Leigh Maria Ramos PlattLos Angeles$981K
Agnes ChenTorrance$792K
Wendy MitchellLos Angeles$749K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →